PROTEOME SCIENCES
PROTEOME SCIENCES
Share · GB0003104196 · 935051 (XLON)
Overview Financial Indicators
0,03 GBP
-11,04 % -0,004 GBP
Closing Price XLON 06.06.2025: 2,90 GBX
London (XLON) · Current prices and charts at MoneyPeak
06.06.2025 07:00

Current Prices from PROTEOME SCIENCES

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
PRM.L
GBX
06.06.2025 07:00
2,90 GBX
3,62 GBX
-19,89 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-11,04 % -13,17 % 5,84 % -24,48 % 5,07 % -31,12 % -13,43 %

Company Profile for PROTEOME SCIENCES Share

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Company Data

Name PROTEOME SCIENCES
Company Proteome Sciences plc
Website https://www.proteomics.com
Primary Exchange XLON London
WKN 935051
ISIN GB0003104196
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Christopher Donovan James Pearce Dip., MSI
Country United Kingdom
Currency GBP
Employees 0,0 T
Address Coveham House, KT11 3EP Cobham
IPO Date 1995-10-03

Ticker Symbols

Name Symbol
Frankfurt PI2.F
London PRM.L

More Shares

Investors who PROTEOME SCIENCES hold also have the following shares in their portfolio:
Cantor Equity Partners I, Inc. - Class A Ordinary Shares
Cantor Equity Partners I, Inc. - Class A Ordinary Shares Share
STEDIN . 19/29 MTN
STEDIN . 19/29 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025